The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status - Liu, S; Wang, D; Chen, B (Lung Cancer, 2011)
et al.